William Garrett Nichols, Chief Medical Officer at Candel Therapeutics, Inc. (CADL), sold 20,856 shares at $7.23 ($151K) on 2025-01-15, disclosed to the SEC on 2025-01-17.
Open-market sale of $151k CADL by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.23 | 10,428 | $75K | 50.0% |
| 2 | $7.23 | 10,428 | $75K | 50.0% |
| Total | $7.23 avg | 20,856 | $151K | 100% |
| Filing → |
| CADL | SELL | 2025-03-20 | $794K | — | Filing → |
| CADL | SELL | 2025-01-10 | $178K | — | Filing → |
| CADL | SELL | 2024-12-03 | $127K | — | Filing → |